Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05465330Completed
Randomised, open-label trial of desflurane (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: N75-p100 amplitude value. Started Jul 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05465330.